The results demonstrated that PAH (0.25, 0.5 and 1 μM) reduced the expression of p65, p50, IKKα and IKKβ in PC-3 cells dose-dependently (Figure 6a). The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.